Login
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
.......... Issued in the interest of Investors"
OTP Verification
Regenerate OTP
Alert Message
Please contact to emkayassist@emkayglobal.com
Select Mobile Number and Email for OTP
Please select Mobile No and Email Id for OTP
Generate password
Customer Guest
Login | Register
Forgot Customer Code
Login | Register|Forgot password?
Would you like to create a personalised login id for logging in to Emkay Website ?
Change Personalised Login ID
As of June 2026 39.91% is owned by Indian Promoters and 60.09% by Public. Top five Promoters holding highest number of shares of Eiko Lifesciences co...more...
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th June 2026more...
The company reported standalone net profit of Rs 1.12 crore for the quarter ended March 31 2026 as compared to Rs 0.90 crore in the same period last ...more...
Re-appointment of M/s NP Rajput & Co as Internal Auditor for FY 2026-27 at the Board Meeting held on 26th May 2026.more...
Audited Financial Results (Standalone and Consolidated) for quarter and year ended 31st March 2026more...
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to con...more...
As of March 2026 39.91% is owned by Indian Promoters and 60.09% by Public. Top five Promoters holding highest number of shares of Eiko Lifesciences c...more...
In view of SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November 2018 and amendments thereto (the said Circular) we wish to info...more...
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and year ended on 31st March 2026 receive...more...
As of February 2026 39.91% is owned by Indian Promoters and 60.09% by Public. Top five Promoters holding highest number of shares of Eiko Li...more...
Allotment of 6 25 000 Equity Shares and 29 50 000 Warrants on preferential basis under SEBI (ICDR) Regulations 2018 through Circulation on Tuesday 24...more...
The company reported standalone net profit of Rs 0.95 crore for the quarter ended December 31 2025 as compared to Rs 0.28 crore in the same ...more...
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ( List...more...
BOARD MEETINGS Company Name : Amerise Biosciences Date : 03-08-2026
Latest Videos